Boai NKY Pharmaceuticals Ltd

About Boai NKY Pharmaceuticals Ltd

Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) is publicly traded company on the Shenzhen stock exchange, the first domestic company to develop and manufacture PVP and PVM/MA products, the 3rd largest Global PVP manufacturer; Our product, KoVidone® and PolyKoVidone® line of products representing Povidone, Crospovidone and Copovidone pharmaceutical excipients. KoVidone®-I (PVP-I) broad spectrum biocidal, antifungal and antiviral agent. OraRez® line of PVM/MA Copolymer and derivatives respresenting functional polymers for bioadhesive/mucoadhesive applications. Pharmaceutical solvents and intermediates; NKY is the first Chinese manufacturer to be EXCiPACTTM GMP certified.all pharmaceutical products manufactured under strict cGMP guidelines, all pharma products handled and packaged in class D cleanrooms, state of the art manufacturing facility, QC equipment and test methods fully validated and fully audit trail compliant; Our environment responsibility, fully compliant with government requirements and regulations, real time monitoring of waste streams, 100% recycling of processing water, complete conversion from coal to natural gas, focus on developing green production processes;Technical Research Cent...

  • CN
  • 2015
    On CPHI since
Contact info
Meet us at

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

Products from Boai NKY Pharmaceuticals Ltd (5)